October 12, 2023 — Franklin Mountain Medical announced today that the Dib UltraNav Transseptal Catheter System, which ...
October 12, 2023 — BioCardia, Inc., a developer of cellular and cell-derived therapeutics for the treatment of ...
October 11, 2023 — Unvaccinated people who have recovered from COVID-19 are at heightened risk of heart complications ...
Cardiac PET/CT represents a major advancement in cardiovascular diagnostics, offering significant clinical and ...
October 11, 2023 — Tenaya Therapeutics, Inc., a clinical-stage biotechnology company with a mission to discover, develop ...
October 11, 2023 — Realizing a vision to deliver the best care to patients close to where they live in northern Ohio, GE ...
October 11, 2023 — A newly-issued American Heart Association presidential advisory identifies the strong connections ...
SPONSORED CONTENT — Studycast is a comprehensive imaging workflow system that allows healthcare professionals to work ...
October 11, 2023 — To gain the latest insight into genetic research for the treatment of hypertrophic cardiomyopathy ...
October 10, 2023 — Axon Therapies, a private company focused on addressing a root cause of heart failure, announced 6 ...
October 10, 2023 — Hawthorne Effect, a complete clinical trials solution, announced interim recruitment results for the ...
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
October 10, 2023 — Elixir Medical, a developer of innovative cardiovascular technologies, announced it will present ...
October 10, 2023 — The recipients of two prestigious awards — the Career Achievement Award and the TCT Geoffrey O ...
The global incidence of non-communicable diseases (NCDs) is currently around 40 million cases a year. Of that total ...
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
October 9, 2023 — The vast majority of people who have a minimally invasive heart valve replacement procedure do not ...
October 9, 2023 — Rejuvenate Bio announced new preclinical efficacy data for RJB-0402, a gene therapy targeting key ...
October 9, 2023 — Endotronix, Inc., a digital health and medical technology company dedicated to advancing the treatment ...
October 12, 2023
